Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: While many publications have been made on burnout of oncologists, few publications have been made on oncologists in France, and none focuses on positive markers of their psychological health. Our study is a national study that studies the role of exercise mode, determinants and consequences of positive markers of psychological health of oncologists in France.
Methodology: The survey was disseminated to oncologists (n=606) by the learned societies or cooperative groups of the different cancer specialties from May to July 2022. The questionnaire assessed relationships between exercise mode, determinants and consequences for work, oncologist health and positive markers of psychological health.
Results: French oncologists have high scores for positive markers of psychological health studied with differences according to speciality, status and mode of exercise. The determinants are the same, with inverse relationships, as those already known for burnout: negative impacts of the pro/personal life balance, perceived stress, workaholism, workload, professional isolation, positive impact of job recognition and management support. Important results concern the relationship of the factors studied with the health of oncologists, work behaviours but also in the relationship with patients (significant impact on empathy and compassion in care).
Conclusion: Our study highlights the managerial and organisational factors that need to be worked on in order to preserve the psychological health of oncologists.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bulcan.2025.05.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Psychological health of oncologists: Determinants and consequences in care].
Bull Cancer
September 2025
UR 1901 QUAlité de vIe et santé PSYchologique (QUALIPSY), université de Tours, Tours, France.
Introduction: While many publications have been made on burnout of oncologists, few publications have been made on oncologists in France, and none focuses on positive markers of their psychological health. Our study is a national study that studies the role of exercise mode, determinants and consequences of positive markers of psychological health of oncologists in France.
Methodology: The survey was disseminated to oncologists (n=606) by the learned societies or cooperative groups of the different cancer specialties from May to July 2022.
Assessing Cancer Patients' Exposure to Treatment Misinformation.
J Cancer Educ
September 2025
Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL, USA.
Understanding when and how patients encounter cancer treatment misinformation (CTM) is essential for developing innovative strategies to combat its spread. However, a major challenge in CTM research is the lack of a reliable and valid tool to assess exposure to misinformation. This study aimed to evaluate patients' exposure to CTM through the exposure to cancer treatment misinformation (ECTM) survey.
View Article and Find Full Text PDFAdvancement of clinical practice in delivering CAR T-cell therapy: impact on healthcare resource utilization and comparison with autologous stem cell transplantation in patients with relapsed/refractory large B-cell lymphomas.
Ann Hematol
September 2025
Institute for Workflow-Management in Health Care, European University of Applied Sciences, Cologne, Germany.
In patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) who are either refractory to first-line therapy or relapse within 12 months, chimeric antigen receptor (CAR) T-cell therapy is more effective than salvage chemotherapy followed by high-dose chemotherapy and autologous stem cell transplantation (ASCT) as second-line therapy. Adoption of CAR T-cell therapy into routine clinical practice involves a period of adaptation and refinement of clinical processes. We aimed to document the evolution of clinical processes for CAR T-cell therapy during 2022 and 2023, and compare healthcare resource utilization (HCRU) associated with CAR T-cell and ASCT processes in routine clinical practice.
View Article and Find Full Text PDFHow to Improve Pancreatic Cancer Network Care Using a Human-Centered Design Sprint.
J Med Internet Res
September 2025
Department of Surgery, Radboudumc, Geert Grooteplein 10 (route 618), Nijmegen, 6525 GA, The Netherlands, 31 0243668086.
Pancreatic cancer is considered a complex cancer requiring specific expertise in diagnostic workup and multimodality treatment. Often, multiple health care providers in different hospitals are involved during patient care. This fragmentation of care challenges health care providers in the network to deliver efficient, coherent, and continuous network care.
View Article and Find Full Text PDFNational survey of radiotherapy and androgen deprivation therapy strategies with PSMA-PET/CT integration in intermediate-risk prostate cancer: TROD 09-007 study.
Can J Urol
August 2025
Department of Radiation Oncology, Baskent University Faculty of Medicine, Ankara, 06490, Turkiye.
Background: Intermediate-risk prostate cancer (IR-PC) represents a heterogeneous group requiring nuanced treatment approaches, and recent advancements in radiotherapy (RT), androgen deprivation therapy (ADT), and prostate-specific membrane antigen positron emission tomography (PSMA-PET/CT) imaging have prompted growing interest in personalized, risk-adapted management strategies. This study by the Turkish Society for Radiation Oncology aims to examine radiation oncologists' practices in managing IR-PC, focusing on RT and imaging modalities to identify trends for personalized treatments.
Methods: A cross-sectional survey was conducted among Turkish radiation oncologists treating at least 50 prostate cancer (PC) cases annually.